Oxford Global Drug Discovery USA Congress 2014 Boston

  • Conference Call
  • Oxford Global Con­fer­ences Ltd are proud to present the Drug Dis­cov­ery USA Con­gress, tak­ing place on 21 – 22 Octo­ber, 2014 in Boston, Mass­a­chu­setts, United States. This con­gress brings together a host of senior level experts to dis­cuss recent devel­op­ments in the indus­try and debate the best strate­gies and solu­tions to improve drug dis­cov­ery going forward.

    The drug dis­cov­ery indus­try is fac­ing a time of seis­mic change; as new tech­nolo­gies develop and promis­ing col­lab­o­ra­tions strengthen, it seems that the pharma land­scape is turn­ing into a prime site for inno­va­tion. This event will look at the emerg­ing method­olo­gies in a series of core areas, includ­ing open inno­va­tion, exter­nal research, high con­tent analy­sis and knowledge-​based design.

    We will also cover novel solu­tions to key dis­cov­ery chal­lenges, such as the need to increase mol­e­c­u­lar com­plex­ity in com­pounds, develop dis­ease applic­a­ble assays and build phys­i­o­log­i­cally rel­e­vant screens. Expert speak­ers will also tackle the big debates cur­rently affect­ing research pipelines – Should we pri­ori­tise phe­no­typic over target-​based screen­ing? How will we utilise dis­cov­ery data later in the pipeline? What can Big Pharma learn from suc­cess­ful biotechs?


    R&D Mod­els For The Future

    • Open inno­va­tion: new ini­tia­tives and indus­try case studies
    • Reviv­ing exist­ing drug prod­ucts: increas­ing ther­a­peu­tic potential
    • Expand­ing ther­a­peu­tic areas: pain, anti-​addiction, orphan diseases
    • Tools for mea­sur­ing the suc­cess of research partnerships
    • Prac­ti­cal inno­va­tion: what can we learn from biotechs?
    • Access­ing exter­nal inno­va­tion: how, where and who

    Screen­ing & Assays: Enabling Technologies

    • Phe­no­typic screen­ing vs target-​based screening
    • High con­tent analy­sis: live cell imag­ing, 3D cell based assays, flow cytometry
    • Devel­op­ing dis­ease rel­e­vant assays
    • New tech­nolo­gies for gene expres­sion profiling
    • iPSC and pri­mary cells: phys­i­o­log­i­cally rel­e­vant assays
    • Tech­nol­ogy plat­form case stud­ies: NMR & SPR

    Dis­cov­ery Chem­istry & Drug Design

    • Frag­ment based and struc­ture based drug discovery
    • Analysing structure-​activity relationships
    • Advances in com­pu­ta­tional chem­istry & knowledge-​based design
    • De-​risking through design: achiev­ing selec­tiv­ity and specificity
    • Increas­ing mol­e­c­u­lar com­plex­ity: con­sid­er­ing sol­u­bil­ity, dru­ga­bil­ity and potency
    • Med­i­c­i­nal chem­istry case studies

    Sup­port­ing Inno­va­tion: Trans­la­tional Approaches & Infor­mat­ics Tools

    • Mak­ing the most of dis­cov­ery data: com­pound opti­mi­sa­tion and safety assessment
    • Util­is­ing pre­dic­tive technologies
    • New data analy­sis and inte­gra­tion platforms
    • Legacy data and col­lab­o­ra­tive strate­gies: tack­ling infor­mat­ics challenges
    • DMPK and ADMET: build­ing an inte­grated pipeline

    Sub­mit a poster

    For atten­dees inter­ested in sub­mit­ting a poster, there are oppor­tu­ni­ties now avail­able. Your poster pre­sen­ta­tion will be located in the exhi­bi­tion room for two days along­side other posters from senior sci­en­tists work­ing in indus­try and academia.

    How to sub­mit your poster

    We will require:

    • Poster title, Abstract (200 words or less)
    • Prin­ci­pal author, Organ­i­sa­tion, Mail­ing address
    • Email, Tele­phone, Fax
    • Addi­tional authors

    In order to secure your board space a fee of £250 plus VAT will be required. The poster should be pre­sented as A0 (841mm x 1189mm) por­trait size.

    To take advan­tage of this oppor­tu­nity you need to be reg­is­tered as a paid del­e­gate over the 2 days. We have lim­ited spaces avail­able so please reg­is­ter soon!

    Who Will Attend

    The Drug Dis­cov­ery USA Con­gress is an exclu­sive event designed for senior level atten­dees from lead­ing phar­ma­ceu­ti­cal and biotech­nol­ogy organ­i­sa­tions, along with highly esteemed mem­bers of aca­d­e­mic and gov­ern­ment insti­tu­tions. Del­e­gates typ­i­cally include VPs, Direc­tors and Global Heads of:

    • Assay devel­op­ment
    • Can­di­date selection
    • Com­pu­ta­tional chemistry
    • Dis­cov­ery information
    • Drug design
    • Drug dis­cov­ery
    • Lead gen­er­a­tion
    • Lead opti­mi­sa­tion
    • Library opti­mi­sa­tion
    • Med­i­c­i­nal chemistry
    • Screen­ing technology
    • Struc­tural biology
    • Tar­get selection
    • Tar­get validation
    starting: ending: 22.10.2014 Location: , Category:


    Conference START 22.10.2014 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Category Organiser More Info Conference Website

    Further interesting Conferences

    Currently we have no similar events listed. Please check our website regulary, subscribe to our RSS-Feed or follow us on twitter for new listings.